Dr. Linetta Koppert, associate professor surgical oncology and clinical epidemiologist at Erasmus MC, Rotterdam, The Netherlands.
Her focus in research is in Quality of breast cancer surgery and development of value based breast cancer care, especially in young breast cancer patients, working with Patient Reported Outcome Measures (PROMs) since October 2015. She contributed to the development of an ICHOM international standard outcome set for primary breast cancer patients (JAMA Oncology 2017) and also for metastastatic breast cancer patients (Br Ca Res Tr 2023) as incentive for better care and facilitation of comparative effectiveness research.
Prediction of outcome forms another important research focus, for example prediction of cosmetic outcome of breast conserving surgery and prediction of radiation fibrosis trough translational research. Moreover de-escalation of breast cancer surgery has her interest and was studied within a large population-based database that showed at least equivalent survival of breast conserving treatment versus mastectomy (analyzed in >129.000 patients). She also studied axilla preserving surgery including Quality of Life endpoints after neo-adjuvant systemic therapy.
She supervises PhD candidates and (co)authored >140 peer reviewed publications. Since 2021 Linetta is director of the national breast cancer registry. She is clinical country lead for the IMI-funded Health Outcomes Observatory (H2O) project aiming to develop and implement standard outcome sets for Diabetes, Inflammatory Bowel Disease and Cancer (lung, metastatic breast and multiple myeloma) within Europe and is PI international VBHC at the Erasmus MC.